Ah. If global IFR is worse than rich-countries’ IFR, that seems to imply that developing countries had lower survival rates, despite their more favourable demographics, which would be sad.
It’s still unclear, and the developing world detection and survival rates are a bit uncertain. I think you could probably get a decent approximation by looking at test positivity rates and testing volume compared to death rates over time in different countries, but I’m not going to put together the model to do it.
We’re doing something related with IFR estimates by age at 1DaySooner, but using seroprevalence data, i.e. only where there is really good data for the estimate. I don’t have results of that yet.
that seems to imply that developing countries had lower survival rates, despite their more favourable demographics, which would be sad.
This isn’t impossible because there seems to be a correlation where people with lower socioeconomic status have worse Covid outcomes, but I still doubt that the IFR was worse overall in developing countries. The demographics (esp. the proportion of people age 70-80, and older) make a huge difference.
But I never looked into this in detail, and my impression was also that for a long time at least, there wasn’t any reliable data.
From excess deaths in some locations, such as Guayaquil (Ecuador), one could rule out the possibility that the IFR in developing countries was incredibly low (it would have been at least 0.3% given plausible assumptions about the outbreak there, and possibly a lot higher).
Ah. If global IFR is worse than rich-countries’ IFR, that seems to imply that developing countries had lower survival rates, despite their more favourable demographics, which would be sad.
It’s still unclear, and the developing world detection and survival rates are a bit uncertain. I think you could probably get a decent approximation by looking at test positivity rates and testing volume compared to death rates over time in different countries, but I’m not going to put together the model to do it.
We’re doing something related with IFR estimates by age at 1DaySooner, but using seroprevalence data, i.e. only where there is really good data for the estimate. I don’t have results of that yet.
This isn’t impossible because there seems to be a correlation where people with lower socioeconomic status have worse Covid outcomes, but I still doubt that the IFR was worse overall in developing countries. The demographics (esp. the proportion of people age 70-80, and older) make a huge difference.
But I never looked into this in detail, and my impression was also that for a long time at least, there wasn’t any reliable data.
From excess deaths in some locations, such as Guayaquil (Ecuador), one could rule out the possibility that the IFR in developing countries was incredibly low (it would have been at least 0.3% given plausible assumptions about the outbreak there, and possibly a lot higher).